Agile Therapeutics, Inc. Retained Earnings
Agile Therapeutics, Inc. had Retained Earnings of -$433.76 million as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-08-12
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$433.76M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$421.88M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$423.17M.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$418.70M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2024-06-30 | -$433.76M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$421.88M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$423.17M 10-Q · filed 2024-08-12 | |
| 2023-09-30 | -$418.70M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$417.90M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$414.09M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$408.70M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$404.77M 10-K · filed 2023-03-23 | -$430.77M 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$398.84M 10-K · filed 2023-03-23 | -$411.11M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$393.68M 10-K · filed 2023-03-23 | -$398.89M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$383.29M 10-K · filed 2023-03-23 | -$387.12M 10-K · filed 2022-03-30 |
| 2021-09-30 | -$363.76M 10-Q/A · filed 2021-12-30 | |
| 2021-06-30 | -$346.99M 10-Q · filed 2021-07-26 | |
| 2021-03-31 | -$329.35M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | -$312.22M 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$294.60M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$279.08M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | -$268.25M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | -$260.37M 10-K · filed 2021-03-01 | |
| 2019-09-30 | -$254.35M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | -$249.92M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | -$246.43M 10-Q · filed 2019-05-03 | |
| 2018-12-31 | -$241.55M 10-K · filed 2020-02-20 | |
| 2018-09-30 | -$237.74M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | -$233.95M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | -$228.60M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | -$221.77M 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$215.53M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | -$208.43M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | -$200.98M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$193.47M 10-K · filed 2018-03-12 | |
| 2016-09-30 | -$188.27M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | -$180.46M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | -$172.04M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$164.73M 10-K · filed 2017-03-15 | |
| 2015-09-30 | -$160.83M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$151.42M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | -$142.93M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | -$134.39M 10-K · filed 2016-03-09 | -$134.39M 10-K · filed 2015-03-26 |
| 2013-12-31 | -$118.31M 10-K · filed 2015-03-26 |